Senseonics Holdings, Inc.
Develops the first long-term, implantable glucose sensor for diabetes management.
SENS | NYSE
Overview
Corporate Details
- ISIN(s):
- US81727U1051
- LEI:
- Country:
- United States of America
- Address:
- 20451 SENECA MEADOWS PARKWAY, 20876 GERMANTOWN
- Website:
- https://www.senseonics.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Senseonics Holdings, Inc. is a medical technology company focused on the design, development, and commercialization of transformative glucose monitoring products for people with diabetes. The company's core product is the Eversense® Continuous Glucose Monitoring (CGM) System, which is the first and only long-term, implantable sensor designed for diabetes management. The system provides continuous glucose readings for extended durations of up to 365 days, aiming to improve glycemic control and simplify daily disease management for patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Senseonics Holdings, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Senseonics Holdings, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Senseonics Holdings, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
